SUD Treatment in Medicaid: Variation by Service Type, Demographics, States and Spending March 28, 2024 Issue Brief Substance use disorders contribute to a growing number of deaths, yet they often go undiagnosed and untreated. While nearly three-quarters of Medicaid enrollees with a diagnosed substance use disorder utilized some type of treatment service in 2020, medication treatment rates varied widely, being much lower for alcohol use disorder than opioid use disorder, and lower among Black enrollees and youth compared to their counterparts. Treatment rates varied considerably across states and average Medicaid spending for people with a diagnosed substance use disorder is over twice as high compared to those without a substance use disorder.
Five Key Facts About Immigrants’ Understanding of U.S. Immigration Laws, Including Public Charge February 29, 2024 Poll Finding From the 2023 KFF/LA Times Survey of Immigrants – the largest nationally representative survey focused on this group – comes five key facts about information gaps regarding public charge rules and how these information gaps can prevent immigrants from getting financial assistance they need.
“Healthification”: The Good and Bad of Making Everything a Health Issue May 8, 2024 From Drew Altman In his new column, KFF President and CEO Drew Altman discusses the pros and cons of labeling socio-economic problems as health issues.
3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States March 5, 2024 News Release The first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores. Although the new over-the-counter pill could broaden access to contraceptive options in the United States, KFF research suggests consumers are…
Election 2024 April 5, 2024 Topic Landing Page This topic page houses KFF resources that are relevant to policy debates in the 2024 elections, including those about abortion, the Affordable Care Act, and Medicare.
10 Key Facts About Women with Medicare April 30, 2024 Issue Brief This brief examines 10 key facts about women with Medicare and presents new statistics on the health, economic and functional status of women with Medicare.
Section 1115 Medicaid Waiver Watch: A Closer Look at Recent Approvals to Address Health-Related Social Needs (HRSN) March 4, 2024 Issue Brief This issue brief provides an overview of how Section 1115 waivers have been used to address the health-related social needs of enrollees, including a summary of recent approvals for eight states.
Abortions Later in Pregnancy in a Post-Dobbs Era February 21, 2024 Issue Brief This brief explains why individuals may seek abortions later in pregnancy, how often these procedures occur, and the various laws which regulate access to abortions later in pregnancy across the country.
The International Health Regulations and the U.S.: Implications of an Amended Agreement June 18, 2024 Issue Brief This brief reviews the proposed revisions to the World Health Organization-based agreement known as the International Health Regulations (IHR), and the implications for the U.S. WHO member states are expected to adopt the revised IHR at the World Health Assembly meeting this year. The U.S. government has been a leading proponent of many of the expected revisions to the IHR. In this analysis we also evaluate some of the criticisms of the revisions to the IHR.
Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency April 10, 2024 Issue Brief The Centers for Medicare and Medicaid Services has recently taken actions to increase transparency in Medicare Advantage, however substantial data gaps remain that limit the ability of policymakers and researchers to conduct oversight and assess the program’s performance, and for Medicare beneficiaries to compare Medicare Advantage plans offered in their area.